13 mm on the day of hCG administration, higher number of oocytes retrieved and top-quality embryos (TQE), with a reasonable clinical pregnancy rate (13%). Moreover, as expected, patients undergoing the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol required significantly higher doses and longer duration of gonadotropins stimulation. CONCLUSION(S): The combined Stop GnRH-ag/ GnRH-ant COH protocol is a valuable tool in the armamentarium for treating "genuine" poor ovarian responders. Further large prospective studies are needed to elucidate its role in POR and to identify the specific characteristics of women (before initiating ovarian stimulation), that will aid both fertility specialists’ counselling and their patients in adjusting the appropriate COH protocol, Acemap"> Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF - Acemap - 开云网页登录

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF

2020
OBJECTIVE: To examine whether the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist protocol may improve conventional IVF/intracytoplasmic sperm injection (ICSI) cycle in poor ovarian response (POR) patients. DESIGN: Cohort historical study. SETTING: Tertiary, University affiliated Medical Center. PATIENT(S): Twenty-three POR patients, defined according to the Bologna criteria, who underwent a subsequent Stop GnRH-agonist combined with multiple-dose GnRH-antagonist controlled ovarian hyperstimulation (COH) protocol, within 3 months of the previous failed conventional IVF/ICSI cycle, were included. For the purposes of this study, we eliminated a bias in this selection by including only "genuine" poor responder patients, defined as those who yielded up to 3 oocytes following COH with a minimal gonadotropin daily dose of 300 IU. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved, number of top-quality embryos, COH variables. RESULT(S): The Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol revealed significantly higher number of follicles >13 mm on the day of hCG administration, higher number of oocytes retrieved and top-quality embryos (TQE), with a reasonable clinical pregnancy rate (13%). Moreover, as expected, patients undergoing the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol required significantly higher doses and longer duration of gonadotropins stimulation. CONCLUSION(S): The combined Stop GnRH-ag/ GnRH-ant COH protocol is a valuable tool in the armamentarium for treating "genuine" poor ovarian responders. Further large prospective studies are needed to elucidate its role in POR and to identify the specific characteristics of women (before initiating ovarian stimulation), that will aid both fertility specialists’ counselling and their patients in adjusting the appropriate COH protocol
    • Correction
    • Source
    • Cite
    • Save
    22
    References
    2
    Citations
    NaN
    KQI
    []
    Baidu
    map